Cargando…
Interleukin-17A influences the vulnerability rather than the size of established atherosclerotic plaques in apolipoprotein E-deficient mice
Interleukin (IL)-17A plays a role in the development of atherosclerotic plaques; however, the mechanism remains unclear. In this study, apolipoprotein E-deficient (ApoE(–/–)) mice were fed a high-fat diet to induce atherosclerosis, followed by the treatment with exogenous recombinant IL-17A or the n...
Autores principales: | Wang, Bo, Hou, Xitan, Sun, Yaning, Lei, Chao, Yang, Sha, Zhu, Yao, Jiang, Yingming, Song, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462543/ https://www.ncbi.nlm.nih.gov/pubmed/36133421 http://dx.doi.org/10.1515/biol-2022-0072 |
Ejemplares similares
-
Coronary Atherosclerotic Plaque Vulnerability Rather than Stenosis Predisposes to Non-ST Elevation Acute Coronary Syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2019) -
Establishment of a Novel Mouse Model for Atherosclerotic Vulnerable Plaque
por: Wang, Xueyu, et al.
Publicado: (2021) -
Visfatin Destabilizes Atherosclerotic Plaques in Apolipoprotein E–Deficient Mice
por: Li, Bo, et al.
Publicado: (2016) -
Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022) -
Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)